In this issue:
- We announce an exclusive new reagent from our Partnership with Stockholm University
- Highlight BIONET growth
- Discuss our expertise in Stable labelled API’s and Intermediates
- Showcase our collaboration with NTZ Labs in advanced in vivo studies for relevant Parkinson´s and Alzheimer´s disease models
- A staff interview with Lorna Bankole
- Profile our event attendance at conferences and exhibitions
Click here to read the full newsletter
